BR0212151A - Uso de compostos para tratar condições resultantes de dano ao nervo corneano após cirurgias de lasik e outras oculares ou traumas - Google Patents
Uso de compostos para tratar condições resultantes de dano ao nervo corneano após cirurgias de lasik e outras oculares ou traumasInfo
- Publication number
- BR0212151A BR0212151A BR0212151-4A BR0212151A BR0212151A BR 0212151 A BR0212151 A BR 0212151A BR 0212151 A BR0212151 A BR 0212151A BR 0212151 A BR0212151 A BR 0212151A
- Authority
- BR
- Brazil
- Prior art keywords
- trauma
- nerve damage
- compounds
- conditions resulting
- treat conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31565201P | 2001-08-29 | 2001-08-29 | |
| PCT/US2002/023871 WO2003020281A1 (en) | 2001-08-29 | 2002-07-23 | Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0212151A true BR0212151A (pt) | 2004-08-24 |
Family
ID=23225436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0212151-4A BR0212151A (pt) | 2001-08-29 | 2002-07-23 | Uso de compostos para tratar condições resultantes de dano ao nervo corneano após cirurgias de lasik e outras oculares ou traumas |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1420791A4 (es) |
| JP (1) | JP2005502678A (es) |
| CN (1) | CN1549718A (es) |
| AR (1) | AR036194A1 (es) |
| BR (1) | BR0212151A (es) |
| CA (1) | CA2455896A1 (es) |
| MX (1) | MXPA04001255A (es) |
| PL (1) | PL368565A1 (es) |
| WO (1) | WO2003020281A1 (es) |
| ZA (1) | ZA200400837B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE525111T1 (de) * | 2003-04-18 | 2011-10-15 | Senju Pharma Co | 2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6- |
| ES2234428B1 (es) * | 2003-12-09 | 2006-11-01 | Universidad Miguel Hernandez | Compuestos para el tratamiento de la sequedad de la superficie ocular provocada por la cirugia fotorrefractiva. |
| CN1997381B (zh) * | 2004-04-23 | 2011-06-08 | 千寿制药株式会社 | 含有pacap及其衍生物的角膜神经突形成促进剂 |
| US7485654B2 (en) | 2004-06-03 | 2009-02-03 | Senju Pharmaceutical Co., Ltd. | Corneal perception recovery drug containing amide compound |
| JPWO2006098292A1 (ja) | 2005-03-15 | 2008-08-21 | 小野薬品工業株式会社 | 眼疾患治療剤 |
| CN113350326B (zh) * | 2021-07-28 | 2023-03-17 | 爱尔眼科医院集团股份有限公司 | 化合物lm22b-10在制备角膜上皮及神经损伤治疗药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166317A (en) * | 1988-10-31 | 1992-11-24 | Houston Biotechnology Incorporated | Neurotrophic factor |
| FR2672213B1 (fr) * | 1991-02-05 | 1995-03-10 | Sanofi Sa | Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres. |
| US5767079A (en) * | 1992-07-08 | 1998-06-16 | Celtrix Pharmaceuticals, Inc. | Method of treating ophthalmic disorders using TGF -β |
| US5604244A (en) * | 1995-06-07 | 1997-02-18 | Alcon Laboratories, Inc. | Intraocular irrigating solution containing a polyamine antagonist |
| TWI246421B (en) * | 1998-12-03 | 2006-01-01 | Alcon Mfg Ltd | Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| AU2001261360A1 (en) * | 2000-05-10 | 2001-11-20 | Alcon, Inc. | R-eliprodil for treating glaucoma |
-
2002
- 2002-07-23 CN CNA028168682A patent/CN1549718A/zh active Pending
- 2002-07-23 WO PCT/US2002/023871 patent/WO2003020281A1/en not_active Application Discontinuation
- 2002-07-23 EP EP02756710A patent/EP1420791A4/en not_active Withdrawn
- 2002-07-23 PL PL02368565A patent/PL368565A1/xx unknown
- 2002-07-23 BR BR0212151-4A patent/BR0212151A/pt not_active Application Discontinuation
- 2002-07-23 MX MXPA04001255A patent/MXPA04001255A/es not_active Application Discontinuation
- 2002-07-23 JP JP2003524588A patent/JP2005502678A/ja not_active Withdrawn
- 2002-07-23 CA CA002455896A patent/CA2455896A1/en not_active Abandoned
- 2002-07-30 AR ARP020102872A patent/AR036194A1/es unknown
-
2004
- 2004-02-02 ZA ZA200400837A patent/ZA200400837B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003020281A1 (en) | 2003-03-13 |
| AR036194A1 (es) | 2004-08-18 |
| PL368565A1 (en) | 2005-04-04 |
| EP1420791A1 (en) | 2004-05-26 |
| CA2455896A1 (en) | 2003-03-13 |
| JP2005502678A (ja) | 2005-01-27 |
| MXPA04001255A (es) | 2004-05-27 |
| ZA200400837B (en) | 2005-02-02 |
| EP1420791A4 (en) | 2004-09-15 |
| CN1549718A (zh) | 2004-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0210241A (pt) | Piranoindazóis e seu uso no tratamento de glaucoma | |
| MY140488A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| DE69521620D1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| ATE303757T1 (de) | Behandlung von augenerkrankungen | |
| ATE238792T1 (de) | Verwendung von makroliden zur behandlung von glaukom | |
| DE69930271D1 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
| DE602005008935D1 (de) | Statine zur behandlung von okularer hypertonie und glaukom | |
| WO2000018387A3 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
| BR0210238A (pt) | Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma | |
| WO2003105781A3 (en) | OPHTHALMIC COMPOSITIONS FOR TREATING EYE HYPERTENSION | |
| BR0212151A (pt) | Uso de compostos para tratar condições resultantes de dano ao nervo corneano após cirurgias de lasik e outras oculares ou traumas | |
| BR9907715A (pt) | Composição oftálmica/método para tratamento de lesão córnea e/ou de estesia córnea deteriordada, sìndrome de olho seco, hipolarcrimação e uso de um inibidor de redutase de aldose | |
| DE60138385D1 (de) | Heilmittel zur behandlung von erkrankungen des sehnervs | |
| DE60135972D1 (de) | Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension | |
| BR0017340A (pt) | Tratamento de trauma e outras indicações | |
| MXPA05014143A (es) | Derivados de cumarina para el tratamiento de trastornos oftalmicos. | |
| DE69525631D1 (de) | Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts | |
| ATE278401T1 (de) | Verwendung von riluzol zur behandlung von akustischen traumazuständen | |
| ATE215824T1 (de) | Mittel zur verminderung des augeninnendrucks | |
| BRPI0417549A (pt) | miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal | |
| BR0212274A (pt) | Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma | |
| BR0215752A (pt) | Piranoindazóis e seu uso no tratamento de glaucoma | |
| BR0015486A (pt) | Ligandos de neurofilina para tratamento de condições oculares | |
| BR0000016A (pt) | Dispositivo para implante intracorneano e processo para tratamento de deformidades da córnea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |